تعداد نشریات | 20 |
تعداد شمارهها | 1,149 |
تعداد مقالات | 10,518 |
تعداد مشاهده مقاله | 45,415,485 |
تعداد دریافت فایل اصل مقاله | 11,291,272 |
Effects of Tranexamic Acid on Bleeding and Hemoglobin Levels in Patients Undergoing Percutaneous Nephrolithotomy: Letter to Editor | ||
Iranian Journal of Medical Sciences | ||
نامه به سردبیر، دوره 45، شماره 2، خرداد 2020، صفحه 148-149 اصل مقاله (121.72 K) | ||
شناسه دیجیتال (DOI): 10.30476/ijms.2020.84261.1382 | ||
نویسنده | ||
Mahdi Shahriari* | ||
Hematology-Oncology Branch, Department of Pediatrics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran | ||
چکیده | ||
With great interest, I read a recently published article (IJMS issue: Volume 44, number 6, November 2019) by Mohammadi and colleagues titled “Effects of tranexamic acid on bleeding and hemoglobin levels in patients with staghorn calculi undergoing percutaneous nephrolithotomy”. In their randomized controlled trial, they evaluated the effect of Tranexamic acid (TXA), as an anti-fibrinolytic agent, in preventing excessive bleeding after percutaneous nephrolithotomy (PCNL). They concluded that “TXA reduced the risk of bleeding during and after PCNL and attenuated the drop in the hemoglobin level in the postoperative period”. Furthermore, in the methods section, they stated: “The exclusion criteria comprised of intravascular coagulation, skeletal disorders, acquired color vision, subarachnoid hemorrhage, drug sensitization, and non-consumption of aspirin, warfarin, or vitamin E”. | ||
کلیدواژهها | ||
Tranexamic Acid | ||
سایر فایل های مرتبط با مقاله
|
||
مراجع | ||
| ||
آمار تعداد مشاهده مقاله: 3,369 تعداد دریافت فایل اصل مقاله: 1,881 |